AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BIOTECH

Net Asset Value Oct 7, 2016

9301_rns_2016-10-07_7b38fb17-5130-4403-9b0c-7c8340b30a25.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

THE BIOTECH GROWTH TRUST PLC - Compliance with Market Abuse Regulation

PR Newswire

London, October 7

The Biotech Growth Trust PLC (“the Company”)

Compliance with Market Abuse Regulation

7 October 2016

The Company confirms that:

a)         all inside information which the Directors and Company may have had has been notified to a Regulated Information Service (“RIS”);

b)         the Company’s net asset value per share is calculated and announced through a RIS on a daily basis;

c)         the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on 30 September 2016, which was announced on 3 October 2016, and the financial information to be published in the announcement of its results for the half year ended 30 September 2016.

Further to an announcement made on 3 October 2016 the Company is, therefore, not prohibited from dealing in its own securities during the closed period, as defined by the Market Abuse Regulation, which will end on the date of the publication of its results for the half year ended 30 September 2016, expected to be on or after 9 November 2016. 

-ENDS-

For further information please contact:

Victoria Hale     Frostrow Capital LLP     020 3 170 8732

Talk to a Data Expert

Have a question? We'll get back to you promptly.